Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 3/20 | 0.49 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.49 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.42 |
| ▸ | BDKRB1 | P46663 | 3/20 | 0.41 |
| ▸ | BRS3 | P32247 | 2/20 | 0.40 |
| ▸ | LTB4R2 | Q9NPC1 | 5/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.37 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2126 | 0.90 | SCN1A (0.48) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL29500197 | 0.87 | SCN1A (0.53) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL28731490 | 0.87 | SCN1A (0.53) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL2301 | 0.84 | SCN1A (0.47) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL1614 | 0.81 | SCN1A (0.47) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL29390423 | 0.79 | SLC6A3 (0.68) | SLC6A3SLC6A4BDKRB1BRS3LTB4R2 | |
| SCHEMBL562 | 0.79 | SLC6A3 (0.68) | SLC6A3SLC6A4BDKRB1BRS3LTB4R2 | |
| SCHEMBL29500184 | 0.79 | ALDH1A1 (0.60) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL28731468 | 0.79 | ALDH1A1 (0.60) | SCN1ASCN2ASCN3ASLC6A3SLC6A4 | |
| SCHEMBL8670912 | 0.78 | SLC6A3 (0.66) | SLC6A3SLC6A4BDKRB1BRS3LTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965592-A | HYPOTENSIVE AGENTS | NOVARTIS CORPORATION (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0443983-B1 | Acyl compounds | CIBA GEIGY AG (CH) | 1996-02-28 | — | — | EP | disclosed |
| US-5399578-A | Hypotensive; valsartan; high blood pressure and cardiac insufficiency | CIBA-GEIGY CORP (US) | 1995-03-21 | — | — | US | disclosed |
| EP-0443983-A1 | Acyl compounds | CIBA-GEIGY AG (CH) | 1991-08-28 | — | — | EP | disclosed |